Free Daily Biotech Industry Newsletter
Get the latest on Biotech & Pharma Deals, Clinical Trials, FDA Decisions, and Key Regulatory Issues sent straight to your Inbox. Join over 150,000 biotech professionals who subscribe to FierceBiotech for FREE!
Shares of Cleveland BioLabs ($CBLI) were trounced yesterday as word spread that a division of Health and Human Services had turned a cold shoulder to its experimental treatment for radiation poisoning.
So-called "orphan diseases" are rare conditions that affect fewer than 200,000 people per year in the U.S. In this Executive Insights, L.E.K. Consulting looks at the changing dynamics of the orphan market and identifies winning strategies designed to capture value within this sector. Download today!
FierceBiotech monitors biotech & pharma deals, FDA decisions, clinical trials, and more. Join more than 150,000 biotech industry leaders who subscribe to our free daily email. Click here to get your free weekly email briefing today!